Data / Form D filings / Aperiam Bio, Inc.
Aperiam Bio, Inc.: Form D filings
Aperiam Bio, Inc., a biotechnology company in Austin, TX, filed 2 Form D notices with the SEC between 2022 and 2023. The latest, on September 27, 2023, reports $4 million sold of an offering with no set size to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2205 NORTH LAMAR BLVD. UNIT 511, Austin, TX, 78705
- Phone
- (512) 318-5584
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1911739
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 27, 2023 | New notice | Indefinite | $3,999,996 | 2 | Sep 18, 2023 | sec.gov | |
| Mar 7, 2022 | New notice | Indefinite | $3,660,002 | 3 | Jan 31, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Austin Cole | Executive Officer, Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Sep 25, 2023 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Aperiam Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.